Aimmune Therapeutics, Inc.

Q2 2017 13F Holders

Symbol
AIMT
CUSIP
00900T107
Type
Equity
Class
COM
Num filings
98
Total reported value, excl. options
$757 M
Manager Report Date Value ($000) Shares Option Type